Global Erectile Dysfunction Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Scope of the Report:

The worldwide market for Erectile Dysfunction Drugs is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 6496.4 million US$ in 2024, from 5188.6 million US$ in 2019, according to a new study.
This report focuses on the Erectile Dysfunction Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Dong-A ST
Metuchen Pharma
BaiYunShan General Factory
Pfizer
Eli Lilly
Bayer
CSBIO.
Teva Pharma
S.K. Chemicals
Seoul Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Sildenafil
Tadalafil
Others

In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

Market Segment by Application

s, can be divided into
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Erectile Dysfunction Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erectile Dysfunction Drugs, with price, sales, revenue and global market share of Erectile Dysfunction Drugs in 2017 and 2018.
Chapter 3, the Erectile Dysfunction Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erectile Dysfunction Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Erectile Dysfunction Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Erectile Dysfunction Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.